Every 8-K that BCHTD (BCHTD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow BCHTD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BCHTD filings page.
Birchtech Corp. has appointed experienced finance executive Michael Mioska, CPA, MBA, as Chief Financial Officer. He has over 20 years of accounting, audit and financial reporting experience across the United States and Canada and has consulted for Birchtech since 2023.
Mioska has worked closely with Birchtech’s finance team, giving him deep familiarity with the company’s operations, systems and strategic priorities. Management expects his capital markets, M&A and reporting expertise to support the next phase of growth in Birchtech’s specialty activated carbon air and water treatment businesses.
Birchtech Corp. set the date for its 2026 Annual Meeting of Stockholders for Thursday, July 23, 2026, to be held as a virtual-only meeting conducted via remote communications. The company will provide the exact time, access details, and agenda items in its upcoming proxy statement.
Because no annual meeting was held in 2025, stockholders seeking to include proposals in the 2026 proxy materials under Rule 14a-8 must deliver them to the company’s Corsicana, Texas headquarters by the close of business on May 26, 2026. The same deadline applies to stockholder proposals or director nominations submitted outside Rule 14a-8, all of which must satisfy the advance notice provisions in Birchtech’s amended and restated bylaws.
Birchtech Corp. expanded its recent stock sale through a partial use of the underwriters’ over-allotment option. The company originally sold 6,250,000 common shares at $2.40 per share, generating gross proceeds of $15.0 million.
On March 17, 2026, the underwriters bought an additional 600,000 shares at the same price, adding approximately $1.4 million of gross proceeds. In total, 6,850,000 shares have been issued in the offering, with aggregate gross proceeds of about $16.4 million and 337,500 over-allotment shares still available.
Birchtech Corp. completed an underwritten public offering of 6,250,000 shares of common stock at $2.40 per share, generating approximately $13.1 million in net proceeds. Underwriters also have a 30‑day option to buy up to 937,500 additional shares, which would lift net proceeds to about $15.2 million if fully exercised.
The company plans to use the cash, together with existing funds, for ongoing operating expenses, working capital and other general corporate purposes. Birchtech’s CEO purchased $750,000 of stock in the deal, or 312,500 shares, and directors and executive officers agreed to a 90‑day lock‑up. The offering supports Birchtech’s uplisting, as its common stock was approved for trading on the NYSE American under the symbol BCHT while remaining listed on the Toronto Stock Exchange.